ASSESSMENT OF NOVEL BIOMARKERS FOR RESTENOSIS OCCURRENCE AFTER DRUG-ELUTING STENT IMPLANTATION IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE AND TYPE 2 DIABETES MELLITUS

被引:0
|
作者
Melnikov, Ivan [1 ]
Gabbasov, Zufar [1 ]
Kozlov, Sergey [2 ]
Byazrova, Svetlana [1 ]
Saburova, Olga [1 ]
机构
[1] Russian Cardiol Res & Prod Complex, Lab Stem Cells, Moscow, Russia
[2] Russian Cardiol Res & Prod Complex, Dept Atherosclerosis, Moscow, Russia
基金
俄罗斯科学基金会;
关键词
D O I
10.1016/j.atherosclerosis.2017.06.390
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PO037
引用
收藏
页码:E121 / E122
页数:2
相关论文
共 50 条
  • [1] Novel Biomarkers for Coronary Restenosis Occurrence After Drug-Eluting Stent Implantation in Patients With Diabetes Having Stable Coronary Artery Disease
    Gabbasov, Zufar
    Kozlov, Sergey
    Melnikov, Ivan
    Byazrova, Svetlana
    Saburova, Olga
    Prokofieva, Lyudmila
    Caprnda, Martin
    Curilla, Eduard
    Gaspar, Ludovit
    Rodrigo, Luis
    Kruzliak, Peter
    Smirnov, Vladimir
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2018, 24 (08) : 1308 - 1314
  • [2] Multiple predictors of coronary restenosis after drug-eluting stent implantation in patients with diabetes
    Hong, S. J.
    Kim, M. H.
    Ahn, T. H.
    Ahn, Y. K.
    Bae, J. H.
    Shim, W. J.
    Ro, Y. M.
    Lim, D-S
    HEART, 2006, 92 (08) : 1119 - 1124
  • [3] OCCURRENCE OF IN-STENT RESTENOSIS AFTER CORONARY DRUG-ELUTING STENT IMPLANTATION IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Kwon, O. C.
    Seo, W. J.
    Oh, J. S.
    Hong, S.
    Lee, C. -K.
    Yoo, B.
    Kim, Y. -G.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 289 - 289
  • [4] Blood level of CD45+platelets and development of restenosis after drug-eluting stent implantation in patients with stable coronary artery disease
    Gabbasov, Zufar
    Kozlov, Sergey
    Byazrova, Svetlana
    Saburova, Olga
    Melnikov, Ivan
    Caprnda, Martin
    Curilla, Eduard
    Gaspar, Ludovit
    Kruzliak, Peter
    Smirnov, Vladimir
    WIENER KLINISCHE WOCHENSCHRIFT, 2016, 128 (23-24) : 898 - 905
  • [5] Blood level of CD45+ platelets and development of restenosis after drug-eluting stent implantation in patients with stable coronary artery disease
    Zufar Gabbasov
    Sergey Kozlov
    Svetlana Byazrova
    Olga Saburova
    Ivan Melnikov
    Martin Caprnda
    Eduard Curilla
    Ludovit Gaspar
    Peter Kruzliak
    Vladimir Smirnov
    Wiener klinische Wochenschrift, 2016, 128 : 898 - 905
  • [6] Impact of diabetes mellitus and coronary artery disease complexity on outcomes following drug-eluting stent implantation
    Melzi, Gloria
    Cosgrave, John
    Corbett, Simon
    Babic, Rade
    Airoldi, Flavio
    Chieffo, Alaide
    Sangiorgi, Giusseppe G. M.
    Carlino, Mauro
    Michev, Iassen
    Montofarno, Matteo
    Colombo, Antonio
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (8A): : 115M - 115M
  • [7] Glycosylated hemoglobin level as a strong predictor of restenosis after drug-eluting stent implantation in diabetes mellitus patients
    Lee, BK
    Hong, MK
    Lee, CW
    Kim, YH
    Lee, SW
    Jang, JS
    Kang, DH
    Cheong, SS
    Song, JK
    Kim, JJ
    Park, SW
    Park, SJ
    CIRCULATION, 2005, 112 (17) : U675 - U675
  • [8] Coronary Artery Aneurysms After Drug-Eluting Stent Implantation
    Aoki, Jiro
    Kirtane, Ajay
    Leon, Martin B.
    Dangas, George
    JACC-CARDIOVASCULAR INTERVENTIONS, 2008, 1 (01) : 14 - 21
  • [9] Stent restenosis and the use of drug-eluting stents in patients with diabetes mellitus
    Sarembock I.J.
    Current Diabetes Reports, 2004, 4 (1) : 13 - 19
  • [10] Association Between Atherogenic Index of Plasma and Atherogenic Coefficient and in-Stent Restenosis After Drug-eluting Stent Implantation for Stable Coronary Artery Disease
    Yuksel, Yasin
    Yildiz, Cennet
    Ayca, Burak
    Katkat, Fahrettin
    Efe, Suleyman Cagan
    Karabulut, Dilay
    Caglar, Fatma Nihan Turhan
    ISTANBUL MEDICAL JOURNAL, 2023, 24 (01): : 76 - 82